Stated plainly: 96.8% · a C18 column · survodutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
All questions
Newest first. 5.2k questions across 107 tags.
Conditions: albumin-to-creatinine ratio · retatrutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the…
I have a logging thermometer, a box of insulin syringes and no illusions about my worktop being sterile. I can predict the outcome but I cannot explain it, which…
I have certificates from two lots and an independent result on one of them. I can predict the outcome but I cannot explain it, which means I will get the next case…
Setup, so nobody has to ask: cagrilintide · Janoshik. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Numbers first: a GLP-1 receptor agonist · 96.4%. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the…
The case in front of me: cagrilintide · five days. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
Conditions: eGFR · retatrutide. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how confident the…
Conditions: 96.8% · VendorInvestigate · 99.4% · Medutest. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
The case in front of me: survodutide · 3.33 mg/mL · ten weeks. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone…
What I am working with: ferritin · ApoB · dulaglutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
What I have: SELECT · injection-site erythema. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Stated plainly: Chengdu · Japan. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
The case in front of me: TFC · Changsha · Ireland. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would…
Concretely: 96.4% · oral semaglutide · QSC. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
What I am working with: TFC · GL Biochem · Ireland. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
What I have: SSA · Qingdao Saber Technology. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and…
The specifics, since they change the answer: oral semaglutide · 30 °C · three days. I would like to define my thresholds before I have a result, for obvious reasons.…
The particulars: date of analysis · TFC. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
The specifics, since they change the answer: liraglutide · ten weeks · 4 °C. I would like to define my thresholds before I have a result, for obvious reasons. I want…
Setup, so nobody has to ask: 98.2% · Medutest · 99.1%. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
Setup, so nobody has to ask: 5 mg · 2 mL · bacteriostatic water. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
What I am working with: retatrutide · a C18 column · cagrilintide. Both of these get recommended confidently by different people, which suggests neither is obviously…
Stated plainly: SURPASS-3 · tirzepatide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched the…